Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL36AP16, or ribosomal protein L36a pseudogene 16, is a processed pseudogene in humans. Pseudogenes are DNA sequences resembling functional genes, but typically do not encode functional proteins due to mutations and lack of regulatory elements. RPL36AP16 is one of many processed pseudogenes derived from the *RPL36A* gene, which encodes ribosomal protein L36a—a component of the 60S ribosomal subunit essential for protein synthesis. While *RPL36A* itself is crucial for ribosomal function, its pseudogenes, including RPL36AP16, do not participate in these cellular processes and have no known biological or pharmacological activity[1][2][4][5]. If you intend to study ribosomal function or pharmacological targets, focus on the protein-coding gene RPL36A rather than pseudogenes like RPL36AP16[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 16 (RPL36AP16).